--- title: "Meditation Facts — What the Research Actually Shows | Vipassana.Life" description: "Stress markers, anxiety, pain, sleep, telomerase, the brain and the risks: what peer-reviewed studies found about meditation, how large the effects were, and which findings did not replicate. With sources." url: https://vipassana.life/meditation-research/ lang: en author: Ocean DYNN site: Vipassana.Life modified: 2026-09-23 --- # Meditation facts: what the research shows Much of what circulates about meditation is overstated. This page keeps to what peer-reviewed studies found, how large the effects were, and where findings failed to replicate. Every claim is followed by its source. ## Stress: the body settles measurably Across 45 randomised trials that compared meditation with an active control, meditation reduced cortisol, C-reactive protein, blood pressure, heart rate, triglycerides and TNF-alpha (Pascoe et al., 2017). Every type of meditation studied reduced systolic blood pressure. ## Anxiety, depression and pain: small, real effects A Johns Hopkins review of 47 trials with 3,515 participants found moderate evidence that mindfulness meditation programmes improve anxiety, depression and pain, with effect sizes of roughly 0.2 to 0.4 — small to moderate. Meditation was not shown to be better than exercise, medication or behavioural therapy (Goyal et al., 2014). ## Sleep In a randomised trial with older adults who had moderate sleep problems, a six-week mindfulness programme improved sleep quality more than a sleep-hygiene course, and also reduced insomnia symptoms, depression symptoms and fatigue (Black et al., 2015). In broader populations the evidence is weaker (Goyal et al., 2014). ## Pain relief that does not rely on endorphins Meditation reduces the intensity and unpleasantness of pain. In a double-blind study, blocking the body's own opioids with naloxone did not remove the relief (Zeidan et al., 2016). The popular claim that meditation works by releasing endorphins is therefore not supported; it appears to work through attention and appraisal instead. ## Telomerase After a three-month residential retreat of about six hours of meditation a day, participants had higher telomerase activity in immune cells than a matched wait-list group (Jacobs et al., 2011). Telomerase maintains the protective ends of chromosomes. The study was small, thirty people per group, did not measure telomerase before the retreat, and studied an intensive retreat rather than daily home practice. ## The brain: an early finding that did not replicate A widely cited study reported increased grey-matter concentration after an eight-week mindfulness course, in sixteen participants (Hölzel et al., 2011). The largest and most rigorously controlled test so far, two combined randomised trials with 218 participants, found no structural brain changes from the same course (Kral et al., 2022). Claims that eight weeks of meditation rewires the brain should be read with that in mind. ## Addiction: a study of Vipassana itself Most research studies secular mindfulness programmes. One controlled study examined a 10-day Vipassana course taught in a jail: after release, participants used significantly less alcohol, marijuana and crack cocaine than a usual-treatment group, and reported fewer alcohol-related problems (Bowen et al., 2006). ## Risks: the part usually left out In a population-based survey of 434 people in the United States who had meditated, 32% reported a meditation-related adverse effect when asked in general, and 50% endorsed at least one specific effect. About 10% had effects lasting a month or more; 1.2% reported impairment lasting a month or more. Anxiety, re-experiencing of trauma and emotional sensitivity were the most common. People who reported adverse effects were as glad to have practised as those who did not (Goldberg et al., 2022). The authors' conclusion is transparency and trauma-sensitivity, not avoidance. ## How this shapes the course Two sittings a day, sittings that lengthen gradually, progress that opens only through practice, and a safety page before the first sitting: the course is built on what the evidence shows, including the risks. ## Sources - Pascoe MC, et al. (2017). Mindfulness mediates the physiological markers of stress: systematic review and meta-analysis. Journal of Psychiatric Research 95:156–178. [doi.org/10.1016/j.jpsychires.2017.08.004](https://doi.org/10.1016/j.jpsychires.2017.08.004) - Goyal M, et al. (2014). Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine 174(3):357–368. [doi.org/10.1001/jamainternmed.2013.13018](https://doi.org/10.1001/jamainternmed.2013.13018) - Black DS, et al. (2015). Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: a randomized clinical trial. JAMA Internal Medicine 175(4):494–501. [doi.org/10.1001/jamainternmed.2014.8081](https://doi.org/10.1001/jamainternmed.2014.8081) - Zeidan F, et al. (2016). Mindfulness-meditation-based pain relief is not mediated by endogenous opioids. Journal of Neuroscience 36(11):3391–3397. [doi.org/10.1523/JNEUROSCI.4328-15.2016](https://doi.org/10.1523/JNEUROSCI.4328-15.2016) - Jacobs TL, et al. (2011). Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology 36(5):664–681. [doi.org/10.1016/j.psyneuen.2010.09.010](https://doi.org/10.1016/j.psyneuen.2010.09.010) - Hölzel BK, et al. (2011). Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Research: Neuroimaging 191(1):36–43. [doi.org/10.1016/j.pscychresns.2010.08.006](https://doi.org/10.1016/j.pscychresns.2010.08.006) - Kral TRA, et al. (2022). Absence of structural brain changes from mindfulness-based stress reduction: two combined randomized controlled trials. Science Advances 8(20):eabk3316. [doi.org/10.1126/sciadv.abk3316](https://doi.org/10.1126/sciadv.abk3316) - Bowen S, et al. (2006). Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors 20(3):343–347. [doi.org/10.1037/0893-164X.20.3.343](https://doi.org/10.1037/0893-164X.20.3.343) - Goldberg SB, Lam SU, Britton WB, Davidson RJ (2022). Prevalence of meditation-related adverse effects in a population-based sample in the United States. Psychotherapy Research 32(3):291–305. [doi.org/10.1080/10503307.2021.1933646](https://doi.org/10.1080/10503307.2021.1933646) - [Before you begin](https://vipassana.life/safety/) - [What you build](https://vipassana.life/vipassana-benefits/) - [What this practice helps you release](https://vipassana.life/vipassana-for-stress-and-habits/) [Open the course →](https://vipassana.life/)